Ask AI
ProCE Banner Events

Evolving Evidence in First-Line Advanced Biliary Tract Cancer

Key Takeaways

  • Describe the current first-line treatment paradigm for advanced biliary tract cancer, including the role of immunotherapy-based combinations 
  • Review long-term overall survival data from pivotal trials and discuss what extended follow-up reveals about durability of benefit 
  • Evaluate emerging real-world evidence in advanced biliary tract cancer and consider how these data inform treatment decisions in routine clinical practice  
Time and location

Tuesday, April 14, 2026

12:15 PM - 12:45 PM Pacific Time (PT)

Virtual